Complete Remission Rate Following 1st induction, following 2nd induction if applicable [clinicaltrials_resource:4e251621e932a5a3314c48cd07bee08e]
CPX-351 at 100u/m2 will be administered on study days 1, 3 and 5 as a 90 minute infusion
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Complete Remission Rate Following 1st induction, following 2nd induction if applicable [clinicaltrials_resource:4e251621e932a5a3314c48cd07bee08e]
CPX-351 at 100u/m2 will be administered on study days 1, 3 and 5 as a 90 minute infusion
Bio2RDF identifier
4e251621e932a5a3314c48cd07bee08e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4e251621e932a5a3314c48cd07bee08e
measure [clinicaltrials_vocabulary:measure]
Complete Remission Rate
time frame [clinicaltrials_vocabulary:time-frame]
Following 1st induction, following 2nd induction if applicable
description
CPX-351 at 100u/m2 will be administered on study days 1, 3 and 5 as a 90 minute infusion
identifier
clinicaltrials_resource:4e251621e932a5a3314c48cd07bee08e
title
Complete Remission Rate Following 1st induction, following 2nd induction if applicable
@en
type
label
Complete Remission Rate Follow ...... 51621e932a5a3314c48cd07bee08e]
@en